Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
LONDON, Oct. 18, 2016 (GLOBE NEWSWIRE) -- Winterhawk Consulting Ltd. and Velocity Technology Solutions, in partnership with SAP, are pleased to announce a one-day event “Cyber, Fraud and Data...
-
SALT LAKE CITY, Oct. 18, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, announced today that more than 40 of its...
-
SAN DIEGO, Oct. 17, 2016 (GLOBE NEWSWIRE) -- SENTÉ, a privately held specialty aesthetics company pioneering the development of differentiated medical grade skincare products based on the science of...
-
SALT LAKE CITY, Oct. 17, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced it will present four new studies...
-
IRVINE, Calif., Oct. 10, 2016 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for...
-
SALT LAKE CITY, Oct. 07, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that four poster presentations...
-
FORT COLLINS, Colo., Oct. 6, 2016 (GLOBE NEWSWIRE) -- Green Sun Medical, a Colorado-based startup company developing a transformative bracing technology for the treatment of adolescent scoliosis, was...
-
AUSTIN, Texas, Oct. 06, 2016 (GLOBE NEWSWIRE) -- data.world today announced its participation in the White House’s “Opportunity Project”, a new open data effort to improve economic mobility...
-
SALT LAKE CITY, Oct. 03, 2016 (GLOBE NEWSWIRE) -- Note: the titles and abstract numbers have been corrected. Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN),...
-
VANCOUVER, British Columbia and DOYLESTOWN, Pa., Oct. 03, 2016 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq:ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions...